Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis. Mol Neurobiol. 2018 01; 55(1):267-275.
View in:
PubMed
subject areas
Animals
Aza Compounds
Cell Line
Encephalomyelitis, Autoimmune, Experimental
Male
Mice
Myelin Basic Protein
Treatment Outcome
authors with profiles
Azizul Haque
Craig Cano Beeson